Nitsan Halevy
Chief Tech/Sci/R&D Officer at PLURI INC.
Profile
Nitsan Halevy is currently the Chief Medical Officer at Pluri, Inc. Prior to this, she worked as the Chief Development Officer at Quark Pharmaceuticals, Inc. She holds a doctorate degree from Ben-Gurion University of the Negev.
Nitsan Halevy active positions
| Companies | Position | Start |
|---|---|---|
| PLURI INC. | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Former positions of Nitsan Halevy
| Companies | Position | End |
|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Training of Nitsan Halevy
| Ben-Gurion University of the Negev | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PLURI INC. | Health Technology |
| Private companies | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Nitsan Halevy
